{"id":"W4408555362","doi":"10.1055/s-0045-1804605","title":"Baseline characteristics of patients enrolled in FIBRONEER(TM)-IPF, a Phase III randomised placebo-controlled trial of the preferential PDE4B inhibitor BI 1015550 in patients with idiopathic pulmonary fibrosis","year":2025,"lang":"en","type":"article","venue":"Pneumologie","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Medicine; Placebo; Idiopathic pulmonary fibrosis; Internal medicine; Gastroenterology; Lung; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001143022,0.000634859,0.001629584,0.0002916797,0.0004193762,0.0006050247,0.0003036359,0.001163208,0.005325465],"category_scores_gemma":[0.001659784,0.0003397508,0.0009976693,0.0004919753,0.0004032877,0.0008270674,0.0002230873,0.001398755,0.0005886534],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004081371,"about_ca_system_score_gemma":0.0004898051,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007235135,"about_ca_topic_score_gemma":0.0008924668,"domain_scores_codex":[0.9992704,0.0001888714,0.00008443847,0.0001802839,0.00008045121,0.0001956465],"domain_scores_gemma":[0.9992,0.0002187882,0.0001912905,0.00005943302,0.00007122086,0.0002591895],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7860198,0.007983067,0.1495518,0.000893998,0.0029139,0.0004732892,0.0001955667,0.001362676,0.01161342,0.0003993919,0.004440438,0.0341527],"study_design_scores_gemma":[0.1329836,0.1157745,0.7366536,0.0001648796,0.001964607,0.0007044262,0.0002755902,0.001747969,0.001226064,0.000845711,0.007516775,0.0001423538],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9839982,0.004428101,0.0005352417,0.0002361405,0.0001442241,0.0008313949,0.006106518,0.00002404263,0.003696174],"genre_scores_gemma":[0.989423,0.000682692,0.00029995,0.0006204207,0.0001422708,0.001134957,0.005432894,0.000007427545,0.002256323],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005325465,"threshold_uncertainty_score":0.01781547,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006961559503105179,"score_gpt":0.2415424038703154,"score_spread":0.2345808443672103,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}